Revenue and Profit Trends
Examining the company's net sales from March 2019 through March 2025 reveals a notable increase from ₹86.90 crores in 2019 to ₹122.06 crores in 2025. Despite some volatility, including a dip in 2021 to ₹49.93 crores, the overall trend indicates recovery and expansion. Total operating income mirrors this pattern, with no other operating income reported during this period.
Operating profit before depreciation, interest, and tax (PBDIT) excluding other income showed a rise from ₹2.40 crores in 2019 to ₹5.48 crores in 2025, peaking at ₹6.31 crores in 2023. When factoring in other income, operating profit improved further, reaching ₹8.78 crores in 2025. However, interest expenses have also increased, from ₹0.86 crores in 2019 to ₹4.55 crores in 2025, which has compressed the gross profit before depreciation and tax (PBDT) to ₹4.23 crores in 2025.
Profit before tax (PBT) and profit after tax (PAT) have shown a similar pattern of growth with fluctuations. PAT rose from ₹1.27 crores in 2019 to ₹2.51 crores in 2025, with margins improving to 2.06% in 2025 from 1.46% in 2019. Earnings per share (EPS) have varied, with a peak of 3.17 in 2019, a dip in subsequent years, and a recovery to 1.85 in 2025.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
Cost Structure and Margins
The company's cost of raw materials and purchase of finished goods constitute the bulk of its expenditure. Raw material costs fluctuated, reaching ₹18.68 crores in 2025, while purchases of finished goods increased to ₹89.02 crores in the same year. Other expenses also rose steadily, reflecting increased operational activities.
Operating profit margins excluding other income have ranged between 2.76% in 2019 and 6.55% in 2023, settling at 4.49% in 2025. Gross profit margins have similarly varied, peaking at 4.54% in 2023 and standing at 3.47% in 2025. These figures suggest moderate profitability with some pressure from rising costs and interest expenses.
Balance Sheet and Financial Position
Shareholder's funds have seen a significant increase from ₹11.98 crores in 2021 to ₹47.24 crores in 2025, supported by a rise in equity capital and reserves. The equity capital increased notably from ₹4.00 crores in 2019 to ₹13.56 crores in 2025, while reserves expanded from ₹6.80 crores to ₹33.68 crores over the same period.
Total liabilities have grown from ₹55.68 crores in 2020 to ₹100.58 crores in 2025, with total debt peaking at ₹36.96 crores in 2024 before declining to ₹26.50 crores in 2025. Long-term borrowings have decreased substantially, indicating some deleveraging, while short-term borrowings have increased, reflecting changes in working capital management.
On the asset side, net block values have risen from ₹9.25 crores in 2020 to ₹17.61 crores in 2025, showing investment in fixed assets. Current assets have also increased significantly, reaching ₹73.74 crores in 2025, driven by higher inventories and sundry debtors, which may indicate expanded operations but also potential working capital challenges.
Cash Flow and Liquidity
Cash flow from operating activities has been inconsistent, with a negative outflow of ₹13 crores in 2025 contrasting with positive inflows in prior years. Investing activities have seen substantial outflows, particularly in 2025, reflecting capital expenditure or investments. Financing activities have provided significant inflows in 2025, suggesting reliance on external funding to support operations and investments.
Despite these fluctuations, the company ended 2025 with a modest positive net cash inflow and a closing cash balance of ₹3 crores, indicating some liquidity cushion.
Trident Texofab or something better? Our SwitchER feature analyzes this Microcap Garments & Apparels stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary and Outlook
Trident Texofab's historical performance reflects a company navigating growth with some volatility in profitability and cash flows. The steady increase in net sales and shareholder equity is encouraging, though rising interest costs and working capital demands present challenges. The company’s ability to manage its debt and improve operating margins will be critical for sustained growth.
Investors should consider these factors alongside market conditions and sector dynamics when evaluating Trident Texofab's prospects. The company’s recent profitability and expanding asset base suggest potential, but cautious monitoring of cash flow and cost management remains advisable.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
